Cargando…

Comparison of the Panther Fusion and Allplex assays for the detection of respiratory viruses in clinical samples

Respiratory viral infections are the most frequent clinical syndrome affecting both children and adults, and early detection is fundamental to avoid infection-related risks and reduce the healthcare costs incurred by unnecessary antibiotic treatments. In this study, performance characteristics of tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Folgueira, Lola, Moral, Noelia, Pascual, Consuelo, Delgado, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934309/
https://www.ncbi.nlm.nih.gov/pubmed/31881030
http://dx.doi.org/10.1371/journal.pone.0226403
_version_ 1783483363522248704
author Folgueira, Lola
Moral, Noelia
Pascual, Consuelo
Delgado, Rafael
author_facet Folgueira, Lola
Moral, Noelia
Pascual, Consuelo
Delgado, Rafael
author_sort Folgueira, Lola
collection PubMed
description Respiratory viral infections are the most frequent clinical syndrome affecting both children and adults, and early detection is fundamental to avoid infection-related risks and reduce the healthcare costs incurred by unnecessary antibiotic treatments. In this study, performance characteristics of two commercial methods, the Panther Fusion® assay (Hologic Inc., San Diego, CA, USA) were compared to Allplex(™) respiratory panels (Seegene, Seoul, South Korea) for the detection of influenza A (Flu A), influenza B (Flu B), respiratory syncytial virus (RSV), parainfluenza virus (PIV), human metapneumovirus (hMPV), rhinovirus (RV) and adenovirus (AdV) targets. A total of 865 specimens collected prospectively and retrospectively were included, and discordant results were further examined using another commercial product, R-GENE(™) respiratory kits (bioMérieux, Marcy l’Etoile, France). There was high agreement between both methods, with 98.6% concordance and a kappa (k) value of 0.9 (95% CI: 0.89–0.92). A specific analysis of both methods for each viral agent demonstrated comparable sensitivity and specificity, both ranging from 0.83 to 1 with good predictive values for the prospective part of the study. Good agreement between both methods was also found for the κ values obtained (ranging from 97.55% to 98.9%), with the lowest for hMPV (k = 0.83, 95% CI: 0.75–0.91) and RV (k = 0.73, 95% CI: 0.65–0.81). Amplification efficiency, measured according to the value of the cycle threshold (C(t)) obtained in each of the amplifications in both tests, was significantly better with Panther Fusion for Flu A, Flu B, hMPV and RV. Regarding discordant results, R-GENE showed higher agreement with Panther Fusion-positive specimens (negative for Allplex; n = 28/71, 34.9%) than with Allplex-positive samples (negative for Panther Fusion; n = 7/49, 14.3%). In summary, Panther Fusion proved to be a more efficient fully-automated methodology, requiring shorter hands-on and turnaround times than Allplex.
format Online
Article
Text
id pubmed-6934309
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-69343092020-01-07 Comparison of the Panther Fusion and Allplex assays for the detection of respiratory viruses in clinical samples Folgueira, Lola Moral, Noelia Pascual, Consuelo Delgado, Rafael PLoS One Research Article Respiratory viral infections are the most frequent clinical syndrome affecting both children and adults, and early detection is fundamental to avoid infection-related risks and reduce the healthcare costs incurred by unnecessary antibiotic treatments. In this study, performance characteristics of two commercial methods, the Panther Fusion® assay (Hologic Inc., San Diego, CA, USA) were compared to Allplex(™) respiratory panels (Seegene, Seoul, South Korea) for the detection of influenza A (Flu A), influenza B (Flu B), respiratory syncytial virus (RSV), parainfluenza virus (PIV), human metapneumovirus (hMPV), rhinovirus (RV) and adenovirus (AdV) targets. A total of 865 specimens collected prospectively and retrospectively were included, and discordant results were further examined using another commercial product, R-GENE(™) respiratory kits (bioMérieux, Marcy l’Etoile, France). There was high agreement between both methods, with 98.6% concordance and a kappa (k) value of 0.9 (95% CI: 0.89–0.92). A specific analysis of both methods for each viral agent demonstrated comparable sensitivity and specificity, both ranging from 0.83 to 1 with good predictive values for the prospective part of the study. Good agreement between both methods was also found for the κ values obtained (ranging from 97.55% to 98.9%), with the lowest for hMPV (k = 0.83, 95% CI: 0.75–0.91) and RV (k = 0.73, 95% CI: 0.65–0.81). Amplification efficiency, measured according to the value of the cycle threshold (C(t)) obtained in each of the amplifications in both tests, was significantly better with Panther Fusion for Flu A, Flu B, hMPV and RV. Regarding discordant results, R-GENE showed higher agreement with Panther Fusion-positive specimens (negative for Allplex; n = 28/71, 34.9%) than with Allplex-positive samples (negative for Panther Fusion; n = 7/49, 14.3%). In summary, Panther Fusion proved to be a more efficient fully-automated methodology, requiring shorter hands-on and turnaround times than Allplex. Public Library of Science 2019-12-27 /pmc/articles/PMC6934309/ /pubmed/31881030 http://dx.doi.org/10.1371/journal.pone.0226403 Text en © 2019 Folgueira et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Folgueira, Lola
Moral, Noelia
Pascual, Consuelo
Delgado, Rafael
Comparison of the Panther Fusion and Allplex assays for the detection of respiratory viruses in clinical samples
title Comparison of the Panther Fusion and Allplex assays for the detection of respiratory viruses in clinical samples
title_full Comparison of the Panther Fusion and Allplex assays for the detection of respiratory viruses in clinical samples
title_fullStr Comparison of the Panther Fusion and Allplex assays for the detection of respiratory viruses in clinical samples
title_full_unstemmed Comparison of the Panther Fusion and Allplex assays for the detection of respiratory viruses in clinical samples
title_short Comparison of the Panther Fusion and Allplex assays for the detection of respiratory viruses in clinical samples
title_sort comparison of the panther fusion and allplex assays for the detection of respiratory viruses in clinical samples
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934309/
https://www.ncbi.nlm.nih.gov/pubmed/31881030
http://dx.doi.org/10.1371/journal.pone.0226403
work_keys_str_mv AT folgueiralola comparisonofthepantherfusionandallplexassaysforthedetectionofrespiratoryvirusesinclinicalsamples
AT moralnoelia comparisonofthepantherfusionandallplexassaysforthedetectionofrespiratoryvirusesinclinicalsamples
AT pascualconsuelo comparisonofthepantherfusionandallplexassaysforthedetectionofrespiratoryvirusesinclinicalsamples
AT delgadorafael comparisonofthepantherfusionandallplexassaysforthedetectionofrespiratoryvirusesinclinicalsamples